Literature DB >> 9291190

Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells.

P K Chatterjee1, R P Weerackody, S K Mistry, G M Hawksworth, J S McLay.   

Abstract

The hypertrophy of renal proximal tubular cells occurs as an adaptive response to a variety of stimuli and may be involved with the progression of renal disease. Angiotensin II acting alone or in combination with other growth factors has been implicated in this process. The aims of this study were to identify the role of both angiotensin II and the angiotensin receptor subtypes in DNA synthesis and protein synthesis in human renal proximal tubular cells. Primary cultures of human renal proximal tubular cells were incubated with angiotensin II (10(-10) M, 10(-8) M, 10(-6) M) for 24 to 120 hours either alone or in combination with losartan, PD123319 or 8-bromo-cAMP. Incubation of human proximal tubular cells with angiotensin II (10(-10) M, 10(-8) M) induced a significant early increase in [3H]thymidine uptake by 19% and 56% (P < 0.01), respectively, and a later increase in total protein content by 30% (P < 0.01). The effect of angiotensin II upon DNA and protein synthesis was inhibited by 8-bromo-cAMP and losartan but not by PD 123319, indicating that the responses are mediated via the AT1 receptor and dependent upon the inhibition of adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9291190     DOI: 10.1038/ki.1997.385

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  4 in total

1.  Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.

Authors:  Melissa A Cadnapaphornchai; Diana M George; Amirali Masoumi; Kim McFann; John D Strain; Robert W Schrier
Journal:  Contemp Clin Trials       Date:  2011-01-23       Impact factor: 2.226

2.  Effect of chronic treatment with losartan on streptozotocin-induced renal dysfunction.

Authors:  B Murali; Dhananjay N Umrani; Ramesh K Goyal
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

3.  Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

Authors:  T Dolley-Hitze; F Jouan; B Martin; S Mottier; J Edeline; O Moranne; P Le Pogamp; M-A Belaud-Rotureau; J-J Patard; N Rioux-Leclercq; C Vigneau
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

4.  Renin angiotensin system deregulation as renal cancer risk factor.

Authors:  Paweł Sobczuk; Cezary Szczylik; Camillo Porta; Anna M Czarnecka
Journal:  Oncol Lett       Date:  2017-08-25       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.